Dare Bioscience Inc (DARE)

[nonsequetor]

From Someone Very Smart
Path to 4.5B MC.

+Initial 10m payment from Organon for Xaciato commencements.
+Sales growth from XACIATO creating a close to breakeven or better cash flow within 2 years. Share price is a reflection of expected future value. Strong sales = big upside potential.
+ Ovaprene IDE acceptance. Bayer thinks that Ovaprene could be it's next billion dollar BC option.
+ $20m Ovaprene payment from Bayer. Would show confidence, solidify balance sheet and give investors more confidence.
+Eventual Ovaprene Approval. $300m+ in incentives + double digit royalties.
+ Sildenafil. Highly likely to be a billion+ annual sales drug with no competition if approved. It alone could boost us to a multi-billion dollar market cap.
+ LARC
+ Deeper pipeline

3 - 5 year horizon. Pretty straightforward path to multi-billion territory."

Long shots - Sale of any of the top 4 candidates. BO of company outright. $6-10 overnight.